Dapagliflozin in patients with COVID-19: truth or dare.

Rossello, Xavier; Caimari, Francisca

Rossello, Xavier; Caimari, Francisca.

Rossello X; Cardiology Department, Institut d'Investigació Sanitària Illes Balears, Hospital Universitari Son Espases, Palma 07120, Illes Balears, Spain; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain; Facultad de Medicina, Universitat de les Illes Balears, Palma, Spain; Medical Statistics Department, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: fjrossello@cnic.es.
Caimari F; Endocrinology and Diabetes Department, Hospital Juaneda Miramar, Palma de Mallorca, Spain.

Lancet Diabetes Endocrinol ; 9(9): 550-551, 2021 09.

Article in English | MEDLINE | ID: covidwho-1322420

Subject(s)

COVID-19; Benzhydryl Compounds; Glucosides/therapeutic use; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Lancet Diabetes Endocrinol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google